首页 | 本学科首页   官方微博 | 高级检索  
检索        

药物发现过程中人工智能的应用研究进展
引用本文:李双星,李一昊,林志,张頔,杨艳伟,屈哲,李言川,霍桂桃,吕建军.药物发现过程中人工智能的应用研究进展[J].现代药物与临床,2023,46(9):2030-2036.
作者姓名:李双星  李一昊  林志  张頔  杨艳伟  屈哲  李言川  霍桂桃  吕建军
作者单位:中国食品药品检定研究院, 国家药物安全评价监测中心, 北京市重点实验室, 北京 100176;湖北天勤鑫圣生物科技有限公司, 湖北 武汉 430207
基金项目:中国食品药品检定研究院学科带头人课题(2021X2)
摘    要:人工智能(AI)和机器学习不仅使药物发现和开发实现了质的飞跃,而且帮助药物开发进程进入现代化。机器学习和深度学习算法已应用于药物发现各个阶段,如先导化合物的筛选、多肽合成及小分子药物的发现、最佳给药剂量的确定、类药化合物的设计和药物不良反应的预测、蛋白质间相互作用的预测、虚拟筛选效率的提高、定量构效关系(QSAR)建模和药物重新定位、理化性质和药物靶标亲和力的预测、化合物的结合预测和体内安全性分析、多靶点配体药物分子的设计以及临床试验的设计。简要综述了AI算法和传统化学相结合以提高药物发现的效率以及AI在药物发现过程中的应用研究进展,以期为AI应用于药物发现提供一定参考。

关 键 词:人工智能  药物发现  药物开发  机器学习  定量构效关系  药物靶标
收稿时间:2023/1/28 0:00:00

Research progress in application of artificial intelligence during process of drug discovery
LI Shuangxing,LI Yihao,LIN Zhi,ZHANG Di,YANG Yanwei,QU Zhe,LI Yanchuan,HUO Guitao,LYU Jianjun.Research progress in application of artificial intelligence during process of drug discovery[J].Drugs & Clinic,2023,46(9):2030-2036.
Authors:LI Shuangxing  LI Yihao  LIN Zhi  ZHANG Di  YANG Yanwei  QU Zhe  LI Yanchuan  HUO Guitao  LYU Jianjun
Institution:Beijing Key Laboratory, National Center for safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China;Hubei Topgene Xinsheng Biotechnology Co., Ltd., Wuhan 430207, China
Abstract:Artificial intelligence (AI) and machine learning (ML) not only has made a qualitative leap in drug discovery and development, but also has helped the process of drug development enter modernization. Algorithms of ML and deep learning (DL) have been applied to various phases of drug discovery, such as screening of lead compounds, peptide synthesis and discovery of small molecular drugs, determination of the optimal dosage, design of drug-like compounds and prediction of adverse drug reaction (ADR), prediction of protein-protein interaction, improvement of the efficiency of virtual screening, quantitative structure-activity relationship (QSAR) modeling and drug repositioning, prediction of physicochemical properties and affinity of drug targets, prediction of drug binding and in vivo safety analysis, design of multiple target ligand drug molecules, as well as design of clinical trials. The research progress in the combination of AI algorithm and traditional chemistry to improve the efficiency of drug discovery and application of AI during the process of drug discovery was briefly reviewed, in order to provide some references for using AI for drug discovery in China.
Keywords:artificial intelligence (AI)  drug discovery  drug development  machine learning  quantitative structure-activity relationship (QSAR)  drug targets
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号